SCHEMBL5360147

SCHEMBL5360147

CCOC(=O)[C@H](Cc1ccc(O)cc1)OC

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 4/20 0.51
ESR2 Q92731 4/20 0.51
CA12 O43570 3/20 0.47
CA1 P00915 3/20 0.47
CA2 P00918 3/20 0.47
CA7 P43166 3/20 0.47
CA9 Q16790 3/20 0.47
CA14 Q9ULX7 3/20 0.47
PTGS2 P35354 3/20 0.45
BACE1 P56817 1/20 0.45
MIF P14174 1/20 0.44
PPARA Q07869 1/20 0.43
SLC7A5 Q01650 1/20 0.42
TAAR1 Q96RJ0 2/20 0.42
SLC6A2 P23975 1/20 0.42
TPH1 P17752 1/20 0.41
MMP8 P22894 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3694538 1.00 ESR1 (0.51) ESR1ESR2CA12CA1CA2
SCHEMBL5578945 0.89 PPARA (0.56) PPARA
SCHEMBL5374825 0.89 PPARA (0.56) PPARA
SCHEMBL977514 0.87 PPARA (0.54) ESR1ESR2CA12CA1CA2
SCHEMBL14392121 0.87 PPARA (0.45) ESR1ESR2PPARAMMP8
SCHEMBL977513 0.87 PPARA (0.54) ESR1ESR2CA12CA1CA2
SCHEMBL6419166 0.87 PPARA (0.54) ESR1ESR2CA12CA1CA2
SCHEMBL542970 0.86 ESR1 (0.63) ESR1ESR2MIFSLC7A5TAAR1
SCHEMBL542969 0.86 ESR1 (0.63) ESR1ESR2MIFSLC7A5TAAR1
SCHEMBL5024580 0.86 ESR1 (0.63) ESR1ESR2MIFSLC7A5TAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015029066-A1 POLYMORPHIC FORM OF PYRROLE DERIVATIVE AND INTERMEDIATE THEREOF CADILA HEALTHCARE LIMITED (IN) 2015-03-05 WO disclosed
US-7321056-B2 Selective peroxisome proliferator activated receptor modulators ELI LILLY AND COMPANY (US) 2008-01-22 US disclosed
US-7321056-B2 Selective peroxisome proliferator activated receptor modulators ELI LILLY AND COMPANY (US) 2008-01-22 US disclosed
US-20070276138-A1 Modulators of peroxisome proliferator activated receptors BROOKS DAWN A 2007-11-29 US disclosed
US-20070276138-A1 Modulators of peroxisome proliferator activated receptors BROOKS DAWN A 2007-11-29 US disclosed
US-20070276138-A1 Modulators of peroxisome proliferator activated receptors BROOKS DAWN A 2007-11-29 US disclosed
EP-1697306-B1 SELECTIVE PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR MODULATORS LILLY CO ELI (US) 2007-07-25 EP disclosed
US-7220880-B2 Amide linker peroxisome proliferator activated receptor modulators ELI LILLY AND COMPANY (US) 2007-05-22 US disclosed
US-20070066683-A1 Selective peroxisome proliferator activated receptor modulators ELI LILLY AND COMPANY 2007-03-22 US disclosed
US-20070066683-A1 Selective peroxisome proliferator activated receptor modulators ELI LILLY AND COMPANY 2007-03-22 US disclosed
US-7192982-B2 Modulators of peroxisome proliferator activated receptors LIGAND PHARMACEUTICALS, INC. (US) 2007-03-20 US disclosed
US-7192982-B2 Modulators of peroxisome proliferator activated receptors LIGAND PHARMACEUTICALS, INC. (US) 2007-03-20 US disclosed
US-20060111406-A1 Amide linker peroxisome proliferator activated receptor modulators ELI LILLY AND COMPANY (US) 2006-05-25 US disclosed
EP-1517882-A1 AMIDE LINKER PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR MODULATORS ELI LILLY AND COMPANY (US) 2005-03-30 EP disclosed
US-20050020684-A1 Modulators of peroxisome proliferator activated receptors ELI LILLY AND COMPANY 2005-01-27 US disclosed
CN-1543451-A Receptor modulators activated by peroxizonal proliferators (ppar) 2004-11-03 CN disclosed
WO-2004000789-A9 AMIDE LINKER PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR MODULATORS LILLY CO ELI (US) 2004-03-11 WO disclosed
EP-1392637-A2 MODULATORS OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS ELI LILLY AND COMPANY (US) 2004-03-03 EP disclosed
WO-2004000789-A1 AMIDE LINKER PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR MODULATORS ELI LILLY AND COMPANY (US) 2003-12-31 WO disclosed
WO-2002100813-A2 MODULATORS OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS ELI LILLY AND COMPANY (US) 2002-12-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070066683-A1 Selective peroxisome proliferator activated receptor modulators PPARG, PPARD, PPARA ESR1 1830/4885ESR2 715/4885CA12 4570/4885
US-20050020684-A1 Modulators of peroxisome proliferator activated receptors NCOA4, PPARG, PPARA ESR1 571/4885ESR2 183/4885CA12 3435/4885
US-20070276138-A1 Modulators of peroxisome proliferator activated receptors PPARG, NCOA4, PPARA ESR1 431/4885ESR2 151/4885CA12 3382/4885
US-20060111406-A1 Amide linker peroxisome proliferator activated receptor modulators PPARG, PPARA, PPARD ESR1 136/4885ESR2 52/4885CA12 4686/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.